This is a Validated Antibody Database (VAD) review about human FBXO22, based on 2 published articles (read how Labome selects the articles), using FBXO22 antibody in all methods. It is aimed to help Labome visitors find the most suited FBXO22 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
FBXO22 synonym: FBX22; FISTC1; F-box only protein 22; F-box protein FBX22p44; FIST domain containing 1

Proteintech Group
rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 2d
In order to identify and characterize an inhibitor of the COP9 signalosome, Proteintech Group FBXO22 antibody (Proteintech, 13606-1-AP) was used in western blot on human samples at 1:500 (fig 2d). Nat Commun (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (FF-7)
  • immunoprecipitation; rat; 1:100; fig 1
In order to investigate the regulation of d-serine synthesis, Santa Cruz Biotechnology FBXO22 antibody (Santa Cruz Biotechnology, sc-100736) was used in immunoprecipitation on rat samples at 1:100 (fig 1). J Biol Chem (2014) ncbi
Sigma-Aldrich
mouse monoclonal (6G9)
  • immunoprecipitation; human; fig 1
In order to investigate the regulation of d-serine synthesis, Sigma-Aldrich FBXO22 antibody (Sigma-Aldrich, WH0026263M1) was used in immunoprecipitation on human samples (fig 1). J Biol Chem (2014) ncbi
Articles Reviewed
  1. Schlierf A, Altmann E, Quancard J, Jefferson A, Assenberg R, Renatus M, et al. Targeted inhibition of the COP9 signalosome for treatment of cancer. Nat Commun. 2016;7:13166 pubmed publisher
  2. Dikopoltsev E, Foltyn V, Zehl M, Jensen O, Mori H, Radzishevsky I, et al. FBXO22 protein is required for optimal synthesis of the N-methyl-D-aspartate (NMDA) receptor coagonist D-serine. J Biol Chem. 2014;289:33904-15 pubmed publisher